GFM
IMRX icon

GF Fund Management’s Immuneering IMRX Stock Holding History

GF Fund Management’s Portfolio IMRX Stock Details IMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.6K Buy
1,442
+174
+14% +$892 ﹤0.01% 581
2025
Q4 		$8.34K Buy
+1,268
New +$8.14K ﹤0.01% 593

Other funds holding IMRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

GF Fund Management's IMRX Position: Q1 2026 in Review

GF Fund Management increased its Immuneering (IMRX) stake by 14% in Q1 2026, buying an estimated $892 and bringing the position to 1,442 shares worth $7.6K. The position accounts for ﹤0.01% of the portfolio, ranked #581.

GF Fund Management first reported a position in IMRX in Q4 2025 and has held it in 2 quarters since. The position peaked at $8.34K in Q4 2025. 95 funds tracked by Wall St. Rank hold IMRX as of Q1 2026.

  • GF Fund Management held 1,442 shares of Immuneering worth $7.6K as of Q1 2026.
  • GF Fund Management bought 174 Immuneering shares in Q1 2026, an estimated $892.
  • Immuneering made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #581 holding.
  • GF Fund Management first reported a position in Immuneering in Q4 2025 and has held it in 2 quarters since.
  • GF Fund Management's Immuneering position peaked at $8.34K in Q4 2025.
  • 95 funds tracked by Wall St. Rank held Immuneering as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.